Ocular Surface Squamous Neoplasia: Changes in the Standard of Care 2003 to 2022.

ABSTRACT:

Purpose

The aim of this review was to elucidate treatment preferences for ocular surface squamous neoplasia and to examine the changes in treatment modalities over the past 2 decades.

Methods

An electronic survey was distributed to members of The Cornea Society, Ocular Microbiology and Immunology Group, and 4 international corneal specialist listservs. Questions examined medical and surgical treatment preferences, and results were compared with surveys administered in 2003 and 2012.

Results

A total of 285 individuals responded to the survey; 90% of respondents were self-classified as corneal specialists. Seventy-three percent reported using primary topical monotherapy to treat ocular surface squamous neoplasia as compared with 58% in 2012 ( P = 0.008). Compared with 2

SUBMITTER: Greenfield JA 

PROVIDER: S-EPMC11216900 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature